Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis
Authors:
- Pradeep K. BhatPBPradeep K. Bhat
- Ashish AnejaAAAshish Aneja
- Dilip P. PillaiDPDilip P. Pillai
- 1 December 2012
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (12) , 2410-2415
Abstract
Hypertensive crisis is associated with poor clinical outcomes. Elevated troponin, frequently observed in hypertensive crisis, may be attributed to myocardial supply-demand mismatch or obstructive coronary artery disease (CAD). However, in patients presenting with hypertensive crisis and an elevated troponin, the prevalence of CAD and the long-term adverse cardiovascular outcomes are unknown. We sought to assess the impact of elevated troponin on cardiovascular outcomes and evaluate the role of troponin as a predictor of obstructive CAD in patients with hypertensive crisis. Patients who presented with hypertensive crisis (n = 236) were screened retrospectively. Baseline and follow-up data including the event rates were obtained using electronic patient records. Those without an assay for cardiac Troponin I (cTnI) (n = 65) were excluded. Of the remaining 171 patients, those with elevated cTnI (cTnI ≥ 0.12 ng/ml) (n = 56) were compared with those with normal cTnI (cTnI < 0.12 ng/ml) (n = 115) at 2 years for the occurrence of major adverse cardiac or cerebrovascular events (MACCE) (composite of myocardial infarction, unstable angina, hypertensive crisis, pulmonary edema, stroke or transient ischemic attack). At 2 years, MACCE occurred in 40 (71.4%) patients with elevated cTnI compared with 44 (38.3%) patients with normal cTnI [hazard ratio: 2.77; 95% confidence interval (CI): 1.79-4.27; P < 0.001]. Also, patients with elevated cTnI were significantly more likely to have underlying obstructive CAD (odds ratio: 8.97; 95% CI: 1.4-55.9; P < 0.01). In patients with hypertensive crisis, elevated cTnI confers a significantly greater risk of long-term MACCE, and is a strong predictor of obstructive CAD.Keywords
This publication has 13 references indexed in Scilit:
- Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapyAmerican Heart Journal, 2011
- Elevated troponin level is not synonymous with myocardial infarctionInternational Journal of Cardiology, 2006
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary EmbolismThe American Journal of Cardiology, 2005
- CARDIAC TROPONIN I LEVELS ARE A RISK FACTOR FOR MORTALITY AND MULTIPLE ORGAN FAILURE IN NONCARDIAC CRITICALLY ILL PATIENTS AND HAVE AN ADDITIVE EFFECT TO THE APACHE II SCORE IN OUTCOME PREDICTIONShock, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- The Diagnosis and Management of Hypertensive CrisesChest, 2000
- Hypertensive Urgencies and EmergenciesHypertension, 1996
- Treatment of Hypertensive CrisisNew England Journal of Medicine, 1990